MFRP variant results in nanophthalmos, retinitis pigmentosa, variability in foveal avascular zone

ABSTRACT Background Membrane frizzled-related protein (MFRP) plays a critical role in ocular development. MFRP mutations are known to cause nanophthalmos and, in some cases, retinitis pigmentosa, foveoschisis, and/or optic nerve head (ONH) drusen. The broad clinical spectrum of MFRP mutations necessitates further investigation of specific genotype–phenotype relationships. Materials and Methods We reviewed ophthalmologic and genetic medical records of two affected siblings and one unaffected sibling. Results Genetic testing revealed variants MFRP c.855T>A, p.(Cys285*) and MFRP c.1235T>C, p.(Leu412Pro) in trans in the two affected siblings. In both cases, photopic and scotopic responses were markedly reduced on electroretinogram (ERG), with greater decrease in scotopic function. Optical coherence tomography for both siblings revealed non-cystoid thickening. Blunted foveal reflexes were also observed in both siblings. Notably, foveal avascular zone abnormalities were seen on fundus autofluorescence in only one affected sibling. Conclusions MFRP-related ocular disease may be underrecognized due to its presentation with high hyperopia and possibly subtle retinal findings. Presence of variants MFRP c.855T>A, p.(Cys285*) and MFRP c.1235T>C, p.(Leu412Pro) in trans resulted in nanophthalmos and retinitis pigmentosa without associated foveoschisis or ONH drusen in our patients, consistent with the incomplete phenotype previously described in Neri et al. Abnormalities in the foveal avascular zone have been noted in other case studies and were inconsistently associated with the variants described here, representing a potential area for future investigation.

[1]  D. Bartsch,et al.  Long-Term Effects of Gene Therapy in a Novel Mouse Model of Human MFRP-Associated Retinopathy. , 2019, Human gene therapy.

[2]  G. Antiñolo,et al.  Posterior microphthalmos, retinitis pigmentosa, and foveoschisis caused by a mutation in the MFRP gene: a familial study , 2019, Ophthalmic genetics.

[3]  G. Velez,et al.  Gene Therapy Restores Mfrp and Corrects Axial Eye Length , 2017, Scientific Reports.

[4]  Gabriëlle H S Buitendijk,et al.  Development of Refractive Errors-What Can We Learn From Inherited Retinal Dystrophies? , 2017, American journal of ophthalmology.

[5]  R. Pfundt,et al.  Diagnostic exome sequencing in 266 Dutch patients with visual impairment , 2017, European Journal of Human Genetics.

[6]  Michael Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2015 update) , 2014, Documenta Ophthalmologica.

[7]  S. Tsang,et al.  Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  C. Macaluso,et al.  Membrane frizzled-related protein gene–related ophthalmological syndrome: 30-month follow-up of a sporadic case and review of genotype-phenotype correlation in the literature , 2012, Molecular vision.

[9]  A. J. Roman,et al.  Gene therapy for retinitis pigmentosa caused by MFRP mutations: human phenotype and preliminary proof of concept. , 2012, Human gene therapy.

[10]  S. Moradian,et al.  Nanophthalmos , 2011, Journal of ophthalmic & vision research.

[11]  I. Bhutto,et al.  Developmental Basis of Nanophthalmos: MFRP Is Required for both Prenatal Ocular Growth and Postnatal Emmetropization , 2008, Ophthalmic genetics.

[12]  M. Amato-Almanza,et al.  A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation. , 2006, Molecular vision.

[13]  J. Heckenlively,et al.  Spatial and temporal expression of MFRP and its interaction with CTRP5. , 2006, Investigative ophthalmology & visual science.

[14]  J. Grigg,et al.  Nanophthalmos: Ultrasound biomicroscopy and Pentacam assessment of angle structures before and after cataract surgery , 2006, Journal of cataract and refractive surgery.

[15]  Suqin Guo,et al.  Cataract surgery in the small adult eye. , 2006, Survey of ophthalmology.

[16]  K. Broman,et al.  Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Khairallah,et al.  Posterior segment changes associated with posterior microphthalmos. , 2002, Ophthalmology.

[18]  P. Sieving,et al.  Refractive errors of retinitis pigmentosa patients. , 1978, The British journal of ophthalmology.

[19]  R. Susanna,et al.  Efficacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome. , 2015, Retinal cases & brief reports.

[20]  G. Holder,et al.  The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. , 2008, Survey of ophthalmology.

[21]  H. E. Cross,et al.  Familial nanophthalmos. , 1976, American journal of ophthalmology.